Canna~Fangled Abstracts Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease. Molecules. 2019 Jul 25;24(15). pii: E2702. doi: 10.3390/molecules24152702. Burgaz S1,2,3, García C1,2,3, Gómez-Cañas M1,2,3, Muñoz…Freedom WaresJuly 25, 2019
